Pharmaceuticals

Global Depression Drugs Market 2015-2019

  • TEC250594
  • 107 Pages
  • June 2015
  • Pharmaceuticals
About depression drugs

According to the WHO, depression is a common mental disorder that contributes significantly to the global burden of disease. It affects people across communities
worldwide. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and
poor concentration. Depression can be roughly categorized into six different types. An individual with severe depression can have suicidal thoughts and behaviors.
According to a 2012 estimate by the WHO, about 3,000 suicides take place each day, resulting in more than a million deaths each year. Depression can be recurrent and
can be severely debilitating. Patients with mild depression can be treated with medications, but in cases of moderate or severe depression, the patient needs both
medication and professional psychotherapy in the form of counseling. According to a 2008 report by the WHO, depression affects men and women equally, but women are
more likely to be affected by depression

than men. According to the CDC, depression can lead to many adverse behaviors in an individual such as alcoholism, smoking, and sleep disturbance. According to the CDC
factsheet, in the US, one in every 10 individuals is affected by depression. According to the NIMH in the US, major depressive disorder is one of the most debilitating
disorders in the US and affects about 14.80 million adults aged 18 years and above.

Technavio's analysts forecast the global depression drugs market to grow at a CAGR of 5.25% over the period 2014-2019.

Covered in this report

This report covers the present scenario and the growth prospects of the global depression drugs market for the period 2015-2019. To calculate the market size, the
report considers revenue generated from the sales of various drugs used for the treatment of depression. The global depression drugs market is segmented based on the
mechanism of action of the drugs used to treat depression, as mentioned below:

Tricyclic antidepressants
Serotonin-norepinephrine reuptake inhibitors
Selective serotonin reuptake inhibitors
Monoamine oxidase inhibitors
Others

Technavio's report, Global Depression Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key regions
Americas
APAC
EMEA

Key vendors
Actavis
Bristol-Myers Squibb
Eli Lilly
GlaxoSmithKline
Pfizer

Other prominent vendors
Abbott Laboratories
Addex Therapeutics
Alkermes
AstraZeneca
Aurobindo Pharma
Avanir Pharmaceuticals
Cerecor
Chugai Pharmaceutical
Dart NeuroScience
Dr. Reddy's Laboratories
Edgemont Pharmaceuticals
E-Therapeutics
Euthymics
Evotec
F. Hoffmann-La Roche
Fabre Kramer
Gedeon Richter
H. Lundbeck
Intra-Cellular Therapies
Janssen Pharmaceuticals
Lupin
Luye Pharma
MSI Methylation Sciences
Naurex
Neuralstem
Novartis
Opko Health
Otsuka Pharmaceutical
Pierre Fabre
Shire
SK Biopharmaceuticals
Somerset Pharmaceuticals
Sun Pharmaceutical
Sunovion Pharmaceuticals
Suven
Takeda Pharmaceutical
Teva Pharmaceutical
Torrent Pharmaceuticals
Valeant Pharmaceuticals

Market driver
Rise in patient population
For a full, detailed list, view our report

Market challenge
Threat of expiry of patents
For a full, detailed list, view our report

Market trend
Growing public awareness
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Markets for Antifungal Agents (Anti - Infective) - Industry Analysis, Share, Size, Trends, Opportunities and Forecast, 2012 - 2020

High penetration of conventional drugs used in the treatment of fungal diseases is reducing the growth for anti-fungal agent market. Though these restraints are dominating the market, the application of ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Ovarian Cancer Drugs Market (Drugs and geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation

Ovarian cancer is cancer that affects the ovaries. According to the WHO, an estimated 2,38,700 women were diagnosed with ovarian cancer in 2012. The report analyzes the demand for ovarian ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Urinary Tract Cancer (Types, Diagnostic Techniques, Treatment Procedures and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

One of the early symptoms of urinary tract cancer is the presence of blood in the urine, haematuria. As cited in WHO report urinary tract cancer was the ninth-most highly ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Cancer Therapeutics and Biotherapeutic Market (Technology, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

Cancer is one of the leading causes of death worldwide. According to the World Health Organization, about 8.2 million deaths occurred in 2012 due to cancer. The most ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Human Insulin Market (Product Type, Brand and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>